Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

The Lymphoma Academic Research Organisation

Status: Enrolling

Conditions: Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Treatments: Other: BIA-ALCL

Study type: Observational

Funder types: Other

Identifiers

NCT04220970

BIA-ALCL Registry

Details and patient eligibility

About

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.

Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).

This registry is opened in France and in Belgium

Enrollment: 150 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with an anaplastic large cell lymphoma associated with breast implants

Exclusion criteria

-

Trial design

150 participants in 1 patient group

BIA-ALCL

Treatment:

Other: BIA-ALCL